Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.
Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.